NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Lemonex Inc.

Lemonex Inc.

Private
SeoulHealthcare & Life Scienceshttps://lemonexbio.com/

Last Round

Grant

Jan 4, 2024

Est. Valuation

$196.69M

Total Funding Raised

$31.98M

Company Overview

Lemonex Inc. is a biotechnology company that develops drug delivery technology for cancer immunotherapeutics, antibody therapeutics, and gene therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Advanced Materials, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

drug delivery platformDegradaBALLnon-viral drug deliveryRNA therapeuticsmRNA vaccinesiRNA therapyLNP alternativegene therapyimmuno-oncologythermally stable vaccineCDMOcontract development and manufacturingpandemic preparednesscytokine therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lemonex Inc. Comparables

Compare Lemonex Inc. with similar companies based on industry and business-model similarity.

Lemonex Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Acuitas Therapeutics
77%
Genevant Sciences
77%
Arcturus Therapeutics Holdings Inc.
73%

Lemonex Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 4, 2024
IPOJul 11, 2023
Series CApr 21, 2021
Series BDec 6, 2018
Series AMar 12, 2018

Key People

Founding team and executive leadership

Cheolhee Won

CEO

Executive Team

Dal-Hee Min

CTO

Executive Team

Lemonex Inc. Investors

Notable investors and investment history

Lemonex Inc. investors
InvestorRounds
DA Value InvestmentSeries B
KDB Capital CorpSeries B
Smilegate InvestmentSeries C
CEPIGrant
TS InvestmentSeries B
Samsung Securities Co., Ltd.IPO
Daegyeong InvestmentSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 2, 2026

    Monthly visitors increased 65% MoM.

  • Dec 1, 2025

    Monthly visitors increased 36% MoM.

Lemonex Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lemonex Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lemonex Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range6
Year Founded2013
Last FundingJan 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.